Clin2
NCT07307274Possibly a fitCompleted

Safety study of SYNT-101 in healthy and overweight adults

HealthyOverweight and Obese Adults

Part of Hormones & metabolism clinical trials.

This trial tests a new medicine called SYNT-101 in healthy and overweight adults to see if it is safe and how the body processes it. It may help researchers learn if this drug could be used for weight-related conditions in the future.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
55 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You are generally healthy, based on your medical history and a checkup.
  • You are willing to have blood drawn and follow the study schedule.
  • You do not have a known allergy to the study drug or any of its ingredients.
  • You have not had a serious allergic reaction or life-threatening allergy in the past.
  • You do not have a significant medical condition (like heart, lung, liver, or kidney disease) that has been active in the last 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07708493Not yet recruiting· Phase 1
Study of a new medicine in healthy men with normal or overweight

This study tests how a new medicine (BI 3034701) moves through the body in healthy men who have normal weight or are overweight. It helps find the right dose and understand how the medicine works.

NCT07776041Not yet recruiting· Phase 1
Study of a new injection for healthy volunteers

This trial tests a new injection called SYH2092 in healthy adults, not for treating a disease. Participation helps researchers understand how the drug works in the body and if it is safe. If you qualify, you may be compensated for your time.

Melbourne, Victoria
NCT06324604Recruiting· Phase 1
Safety study of MTX-101 in healthy adults

This trial tests a new drug called MTX-101 in healthy volunteers to see if it is safe and how the body processes it. It helps determine the right dose before testing in patients with certain conditions.

Heidelberg, Victoria
NCT07724431Not yet recruiting· Phase 1
Safety study of CG-0416 in healthy volunteers

This trial tests a new medicine, CG-0416, in healthy people to see if it is safe and how the body processes it. Participants will receive either the drug or a placebo and be monitored closely.

Melbourne, Victoria
NCT06830343Recruiting· Phase 1
Safety study of SYH9017 for overweight and obesity

This study tests a new medication called SYH9017 for people who are overweight or have obesity. It aims to see how safe the drug is, how well it is tolerated, and how the body processes it. Participants will receive either the drug or a placebo and be monitored closely.

Beijing, Beijing Municipality
NCT06635226Recruiting· Phase 1
Safety study of ID110521156 in healthy adults

This study tests a new investigational drug called ID110521156 in healthy adults. The goal is to see if the drug is safe and how the body processes it. It may be for people who are overweight or obese.

Seoul

Hear when a new Overweight and Obese Adults trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.